
New Publication Highlights RAR Modulator Breakthrough
Nevrargenics announces a new peer-reviewed publication in the American Chemical Society's journal Omega, highlighting the unique mechanism of its next-generation RAR modulators and their promise in tackling neurodegenerative diseases like ALS and Alzheimer’s.